MNTA - Momenta Pharmaceuticals EPS beats by $0.15 beats on revenue May, 07 2020 07:13 AM Momenta Pharmaceuticals Inc. Momenta Pharmaceuticals (NASDAQ:MNTA): Q1 GAAP EPS of -$0.34 beats by $0.15.More news on: Momenta Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...